Korean Circulation Journal

The Korean Society of Cardiology (대한심장학회)
권호 표지
DOI QR코드

DOI QR Code

The Practice Pattern of Percutaneous Coronary Intervention in Korea -Based on Year 2014 Cohort of Korean Percutaneous Coronary Intervention (K-PCI) Registry-

  • Gwon, Hyeon-Cheol (Heart Vascular and Stroke Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Jeon, Dong Woon (Division of Cardiology, National Health Insurance Service Ilsan Hospital) ;
  • Kang, Hyun-Jae (Department of Internal Medicine, Seoul National University Hospital) ;
  • Jang, Jae-Sik (Division of Cardiology, Busan Paik Hospital, University of Inje College of Medicine) ;
  • Park, Duk-Woo (Division of Cardiology, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Shin, Dong-Ho (Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University College of Medicine) ;
  • Moon, Keon-Woong (Division of Cardiology, St. Vincent's Hospital, College of Medicine, The Catholic University of Korea) ;
  • Kim, Jung-Sun (Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University College of Medicine) ;
  • Kim, Juhan (Division of Cardiology, Heart Center of Chonnam National University Hospital) ;
  • Bae, Jang-Whan (Department of Internal Medicine, Chungbuk National University College of Medicine) ;
  • Hur, Seung-Ho (Division of Cardiology, Keimyung University Dongsan Medical Center) ;
  • Kim, Byung Ok (Division of Cardiology, Sanggye-Paik Hospital, University of Inje College of Medicine) ;
  • Choi, Donghoon (Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University College of Medicine) ;
  • Han, Kyoo-Rok (Department of Internal Medicine, Kangdong Sacred Heart Hospital, Hallym University Medical Center) ;
  • Kim, Hyo-Soo (Department of Internal Medicine, Seoul National University Hospital)
  • Received : 2017.03.31
  • Accepted : 2017.04.18
  • Published : 2017.05.31
⟨ Previous Next ⟩

Abstract

Background and Objectives: Appropriate use criteria (AUC) was developed to improve the quality of percutaneous coronary intervention (PCI). However, these criteria should consider the current practice pattern in the country where they are being applied. Materials and Methods: The algorithm for the Korean PCI practice pattern (KP3) was developed by modifying the United States-derived AUC in expert consensus meetings. KP3 class A was defined as any strategy with evidence from randomized trials that was more conservative for PCI than medical therapy or coronary artery bypass graft (CABG). Class C was defined as any strategy with less evidence from randomized trials and more aggressive for PCI than medical therapy or CABG. Class B was defined as a strategy that was partly class A and partly class C. We applied the KP3 classification system to the Korean PCI registry. Results: The KP3 class A was noted in 67.7% of patients, class B in 28.8%, and class C in 3.5%. The median proportion of class C cases per center was 2.0%. The distribution of KP3 classes varied significantly depending on clinical and angiographic characteristics. The proportion of KP3 class C cases per center was not significantly dependent on PCI volume, but rather on the percentage of ACS cases in each center. Conclusion: We report the current PCI practice pattern by applying the new KP3 classification in a nationwide PCI registry. The results should be interpreted carefully with due regard for the complex relationships between the determining variables and the healthcare system in Korea.

Keywords

Acknowledgement

Supported by : Korean Society of Cardiology, Korean Society of Interventional Cardiology

References

  1. Patel MR, Dehmer GJ, Hirshfeld JW, et al. ACCF/SCAI/STS/AATS/AHA/ASNC 2009 appropriateness criteria for coronary revascularization: a report by the American college of cardiology foundation appropriateness criteria task force, society for cardiovascular angiography and interventions, society of thoracic surgeons, American association for thoracic surgery, American heart association, and the American society of nuclear cardiology endorsed by the American society of echocardiography, the heart failure society of America, and the society of cardiovascular computed tomography. J Am Coll Cardiol 2009;53:530-53. https://doi.org/10.1016/j.jacc.2008.10.005
  2. Patel MR, Dehmer GJ, Hirshfeld JW, et al. ACCF/SCAI/STS/AATS/AHA/ASNC/HFSA/SCCT 2012 appropriate use criteria for coronary revascularization focused update: a report of the American college of cardiology foundation appropriate use criteria task force, society for cardiovascular angiography and interventions, society of thoracic surgeons, American association for thoracic surgery, American heart association, American society of nuclear cardiology, and the society of cardiovascular computed tomography. J Am Coll Cardiol 2012;59:857-81. https://doi.org/10.1016/j.jacc.2011.12.001
  3. Patel MR, Calhoon JH, Dehmer GJ, et al. ACC/AATS/AHA/ASE/ASNC/SCAI/SCCT/STS 2016 appropriate use criteria for coronary revascularization in patients with ACSs: a report of the American college of cardiology appropriate use criteria task force, American association for thoracic surgery, American heart association, American society of echocardiography, American society of nuclear cardiology, society for cardiovascular angiography and interventions, society of cardiovascular computed tomography, and the society of thoracic surgeons. J Am Coll Cardiol 2017;69:570-91.
  4. Desai NR, Bradley SM, Parzynski CS, et al. Appropriate use criteria for coronary revascularization and trends in utilization, patient selection, and appropriateness of percutaneous coronary intervention. JAMA 2015;314:2045-53. https://doi.org/10.1001/jama.2015.13764
  5. Committee for the Korean guidelines for the management of dyslipidemia. 2015 Korean guidelines for the management of dyslipidemia: executive summary (English translation) Korean Circ J 2016;46:275-306. https://doi.org/10.4070/kcj.2016.46.3.275
  6. Wayangankar SA, Bangalore S, McCoy LA, et al. Temporal trends and outcomes of patients undergoing percutaneous coronary interventions for cardiogenic shock in the setting of acute myocardial infarction: a report from the CathPCI Registry. JACC Cardiovasc Interv 2016;9:341-51. https://doi.org/10.1016/j.jcin.2015.10.039
  7. Brindis RG, Fitzgerald S, Anderson HV, et al. The American college of cardiology-national cardiovascular data registry (ACC-NCDR): building a national clinical data repository. J Am Coll Cardiol 2001;37:2240-5. https://doi.org/10.1016/S0735-1097(01)01372-9
  8. Jernberg T, Attebring MF, Hambraeus K, Shaw RE, Weintraub WS, Williams JF. The Swedish web-system for enhancement and development of evidence-based care in heart disease evaluated according to recommended therapies (SWEDEHEART). Heart 2010;96:1617-21. https://doi.org/10.1136/hrt.2010.198804
  9. Garcia del Blanco B, Hernandez Hernandez F, Rumoroso Cuevas JR, et al. Spanish cardiac catheterization and coronary intervention registry. 23rd Official report of the Spanish society of cardiology working group on cardiac catheterization and interventional cardiology (1990-2013). Rev Esp Cardiol (Engl Ed) 2014;67:1013-23. https://doi.org/10.1016/j.recesp.2014.08.005
  10. Inohara T, Kohsaka S, Miyata H, et al. Appropriateness ratings of percutaneous coronary intervention in Japan and its association with the trend of noninvasive testing. JACC Cardiovasc Interv 2014;7:1000-9. https://doi.org/10.1016/j.jcin.2014.06.006
  11. Palmerini T, Biondi-Zoccai G, Della Riva D, et al. Stent thrombosis with drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis. Lancet 2012;379:1393-402. https://doi.org/10.1016/S0140-6736(12)60324-9
  12. Chan PS, Patel MR, Klein LW, et al. Appropriateness of percutaneous coronary intervention. JAMA 2011;306:53-61.
  13. Chan PS, Rao SV, Bhatt DL, et al. Patient and hospital characteristics associated with inappropriate percutaneous coronary interventions. J Am Coll Cardiol 2013;62:2274-81. https://doi.org/10.1016/j.jacc.2013.07.086
  14. Feldman DN, Naidu SS, Duffy PL. Inappropriate use of the appropriate use criteria (AUC) as a guide for reimbursement. J Invasive Cardiol 2014;26:559-61.

Cited by

  1. Effect of Pre-Procedural Beta-Blocker on Clinical Outcome after Percutaneous Coronary Intervention in Acute Coronary Syndrome : From the 2014 K-PCI Registry vol.60, pp.6, 2017, https://doi.org/10.1536/ihj.19-175